413
Views
35
CrossRef citations to date
0
Altmetric
Papers

Effects of vitamin D supplementation on 25-hydroxyvitamin D, high-density lipoprotein cholesterol, and other cardiovascular disease risk markers in subjects with elevated waist circumference

, , , , &
Pages 318-327 | Published online: 20 Jan 2011

References

  • Adult Treatment Panel III. 2001. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 285:2486–2497.
  • Baraké R, Weiler H, Payette H, Gray-Donald K. 2010. Vitamin D supplement consumption is required to achieve a minimal target 25-hydroxyvitamin D concentration of>or = 75 nmol/L in older people. J Nutr. 140:551–556.
  • Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF. 1998. Vitamin D and its major metabolites: Serum levels after graded oral dosing in healthy men. Osteoporos Int. 8:222–230.
  • Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. 2006. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 84:18–28.
  • Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. 2003. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract. 57:258–261.
  • Bukowska H, Pieczul-Mróz J, Jastrzebska M, CheBųtowski K, Naruszewicz M. 1998. Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol. Atherosclerosis. 137:437–438.
  • Dietary Reference Intakes. 1997. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, D.C: National Academy of Sciences. Institute of Medicine, Food and Nutrition Board.
  • Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W. 2008. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 168:1340–1349.
  • Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:499–502.
  • Giovannucci E. 2007. Can vitamin D reduce total mortality?. Arch Intern Med. 167:1709–1710.
  • Giovannucci E, Liu Y, Hollis BW, Rimm EB. 2008. 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 168:1174–1180.
  • Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DRJr, Bangdiwala S, Tyroler HA. 1989. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 79:8–15.
  • Grundy SM, Brewer HBJr, Cleeman JI, Smith SCJr, Lenfant C, American Heart Association; National Heart, Lung, and Blood Institute. 2004. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 109:433–438.
  • Hall LM, Kimlin MG, Aronov PA, Hammock BD, Slusser JR, Woodhouse LR, Stephensen CB. 2010. Vitamin D intake needed to maintain target serum 25-hydroxyvitamin D concentrations in participants with low sun exposure and dark skin pigmentation is substantially higher than current recommendations. J Nutr. 140:542–550.
  • Hamazaki T, Sawazaki S, Asaoka E, Itomura M, Mizushima Y, Yazawa K, Kuwamori T, Kobayashi M. 1996. Docosahexaenoic acid-rich fish oil does not affect serum lipid concentrations of normolipidemic young adults. J Nutr. 126:2784–2789.
  • Harris WS, Windsor SL, Dujovne CA. 1991. Effects of four doses of n-3 fatty acids given to hyperlipidemic patients for six months. J Am Coll Nutr. 10:220–227.
  • Holick MF, Chen TC. 2008. Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr. 87 Suppl: 1080S–1086S.
  • Huang Y, Zheng Y. 2010. The probiotic Lactobacillus acidophilus reduces cholesterol absorption through the down-regulation of Niemann–Pick C1-like 1 in Caco-2 cells. Br J Nutr. 103:473–478.
  • Jorde R, Sneve M, Torjesen P, Figenschau Y. 2010. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med. 267:462–472.
  • Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. 2007. Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am J Clin Nutr. 85 6: 1586–1591.
  • Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. 2008. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?. J Am Coll Cardiol. 52:1949–1956.
  • Liu E, Meigs JB, Pittas AG, McKeown NM, Economos CD, Booth SL, Jacques PF. 2009. Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr. 139:329–334.
  • Maki KC, Kritsch K, Foley S, Soneru I, Davidson MH. 1997. Age-dependence of the relationship between adiposity and serum low density lipoprotein cholesterol in men. J Am Coll Nutr. 16:578–583.
  • Maki KC, McKenney JM, Reeves MS, Lubin BC, Dicklin MR. 2008. Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia. Am J Cardiol. 102:429–433.
  • Maki KC, Rubin MR, Wong LG, McManus JF, Jensen CD, Marshall JW, Lawless A. 2009. Serum 25-hydroxyvitamin D is an independent predictor of high density lipoprotein cholesterol and metabolic syndrome in men and women. J Clin Lipidol. 3:289–296.
  • Martini LA, Wood RJ. 2006. Vitamin D status and the metabolic syndrome. Nutr Rev. 64:479–486.
  • Mitri J, Hamdy O. 2009. Diabetes medications and body weight. Expert Opin Drug Saf. 8:573–584.
  • Nagpal J, Pande JN, Bhartia A. 2009. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med. 26:19–27.
  • Pereira DI, Gibson GR. 2002. Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol. 37:259–281.
  • Šidák Z. 1971. On probabilities of rectangles in multivariate normal Student distributions: their dependence on correlations. Ann Math Stat. 41:169–175.
  • Theobald HE, Chowienczyk PJ, Whittall R, Humphries SE, Sanders TA. 2004. LDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women. Am J Clin Nutr. 79:558–563.
  • Talwar SA, Aloia JF, Pollack S, Yeh JK. 2007. Dose response to vitamin D supplementation among postmenopausal African American women. Am J Clin Nutr. 86:1657–1662.
  • Vieth R, Chan PC, MacFarlane GD. 2001. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 73:288–294.
  • Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, Heaney RP, Holick MF, Hollis BW, Lamberg-Allardt C, McGrath JJ, . 2007. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr. 85:649–650.
  • Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS. 2008. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 117:503–511.
  • Wolever TM, Spadafora P, Eshuis H. 1991. Interaction between colonic acetate and propionate in humans. Am J Clin Nutr. 53:681–687.
  • Wolever TM, Fernandes J, Rao AV. 1996. Serum acetate:propionate ratio is related to serum cholesterol in men but not women. J Nutr. 126:2790–2797.
  • Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. 2000. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 72:690–693.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.